Abstract
Magnetic field (MF) is being used in antitumor treatment; however, the underlying biological mechanisms remain unclear. In this study, the potency and mechanism of a previously published tumor suppressing MF exposure protocol were further investigated. This protocol, characterized as a 50 Hz electromagnetic field modulated by static MF with time-average intensity of 5.1 mT, when applied for 2 h daily for over 3 consecutive days, selectively inhibited the growth of a broad spectrum of tumor cell lines including lung cancer, gastric cancer, pancreatic cancer and nephroblastoma. The level of intracellular reactive oxygen species (ROS) increased shortly after field exposure and persisted. Subsequently, pronounced DNA damage and activation of DNA repair pathways were identified both in vitro and in vivo. Furthermore, use of free radical scavenger alleviated DNA damage and partially reduced cell death. Finally, this field was found to inhibit cell proliferation, and simultaneously induced two types of programmed cell death, apoptosis and ferroptosis. In conclusion, this tumor suppressing MF could determine cell fate through ROS-induced DNA damage, inducing oxidative stress and activation of the DNA damage repair pathways, eventually lead to apoptosis and ferroptosis, as well as inhibition of tumor growth.
Highlights
Magnetic field (MF) can be categorized to static and dynamic fields
All tumor cell lines used in this study were anaplastic cells derived from highly malignant cases, and non-malignant cell lines derived from the corresponding normal tissues were used in comparison
Most cell lines responded to MF exposure; compared with the non-malignant counterparts, the tumor cells were more susceptible to MF-induced inhibition
Summary
Electromagnetic field (EMF) can be produced by alternating currents (AC). Domestic power cords generate EMF with the frequency of 50–60 Hertz (Hz), which is an extremely low-frequency electromagnetic field (ELF-EMF, 3-3000 Hz). Based on some epidemiology studies focusing on the relationship between the distribution of power cables and the occurrence rate of leukemia [1], WHO International Agency for Research on Cancer classified ELF-EMF as possible carcinogen to humans [2]. The antitumor effect of ELF-EMF and its synergism with conventional chemotherapy is well documented in the literature [3,4,5]. With the advantage of being non-invasive and low in toxicity, EMF is an ideal alternate antitumor therapeutic option. A medical device based on an EMF of
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.